Mahai Chris LaVictoire 4
4 · abrdn Healthcare Investors · Filed Jul 20, 2026
Research Summary
AI-generated summary of this filing
abrdn Healthcare Investors (HQH) Director Mahai Chris LaVictoire Buys 501 Shares
What Happened
- Mahai Chris LaVictoire, a director of abrdn Healthcare Investors (HQH), reported a purchase of 501 shares on 2026-07-16. The filing shows the transaction as code "P" (open market or private purchase) at $20.96 per share, for a total reported value of $10,501. This was a straight purchase (an acquisition), which is generally more informative to investors than routine sales.
Key Details
- Transaction date: 2026-07-16
- Filing date (Form 4): 2026-07-20 (filed within the required two business days — timely)
- Price per share: $20.96
- Shares acquired: 501
- Total value: $10,501 (reported)
- Transaction code: P (open market or private purchase per the filing)
- Shares owned after transaction: not disclosed in the provided filing
- Footnotes/plan info: none reported in the provided data
Context
- This report documents a direct purchase by a company director. Purchases can be interpreted as a positive signal because insiders are adding to their holdings, but filings do not state motives. No options, gifts, or tax-withholding events were indicated in the provided filing.
Insider Transaction Report
Form 4
Mahai Chris LaVictoire
Director
Transactions
- Purchase
Common Stock
2026-07-16$20.96/sh+501$10,501→ 501 total
Signature
/s/ Robert Stieger, by POA from Reporting Person|2026-07-20